Rebecca Cook

Array ( [id] => 3793092 [patent_doc_number] => 05726181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Formulations and compositions of poorly water soluble camptothecin derivatives' [patent_app_type] => 1 [patent_app_number] => 8/461385 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17705 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726181.pdf [firstpage_image] =>[orig_patent_app_number] => 461385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622628 [patent_doc_number] => 05614624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Carbapenem' [patent_app_type] => 1 [patent_app_number] => 8/460209 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64106 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614624.pdf [firstpage_image] =>[orig_patent_app_number] => 460209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805955 [patent_doc_number] => 05830886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Steroid sulphatase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/458352 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4768 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830886.pdf [firstpage_image] =>[orig_patent_app_number] => 458352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726202 [patent_doc_number] => 05681951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Metal catalyzed displacement process' [patent_app_type] => 1 [patent_app_number] => 8/459542 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64268 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 2666 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681951.pdf [firstpage_image] =>[orig_patent_app_number] => 459542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3626361 [patent_doc_number] => 05612477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => '2-(pyrazol-3-yl)carbapenem derivatives' [patent_app_type] => 1 [patent_app_number] => 8/457002 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30252 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 254 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612477.pdf [firstpage_image] =>[orig_patent_app_number] => 457002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3652230 [patent_doc_number] => 05606051 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => '2-(pyrazol-3-yl)carbapenem derivatives' [patent_app_type] => 1 [patent_app_number] => 8/457076 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30204 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 286 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/606/05606051.pdf [firstpage_image] =>[orig_patent_app_number] => 457076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4025001 [patent_doc_number] => 05925774 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Estrenes for inducing hypothalamic effects' [patent_app_type] => 1 [patent_app_number] => 8/460133 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 34 [patent_no_of_words] => 18377 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925774.pdf [firstpage_image] =>[orig_patent_app_number] => 460133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771161 [patent_doc_number] => 05849777 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Cell differentiation induction with mevalonate and mevalonolactone derivatives' [patent_app_type] => 1 [patent_app_number] => 8/456829 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8926 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849777.pdf [firstpage_image] =>[orig_patent_app_number] => 456829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3879009 [patent_doc_number] => 05776455 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Pharmaceutical formulations' [patent_app_type] => 1 [patent_app_number] => 8/457562 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15493 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776455.pdf [firstpage_image] =>[orig_patent_app_number] => 457562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3983710 [patent_doc_number] => 05861390 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Steroid sulphatase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/456122 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5780 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861390.pdf [firstpage_image] =>[orig_patent_app_number] => 456122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3684877 [patent_doc_number] => 05633392 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Estrenes for inducing hypothalamic effects' [patent_app_type] => 1 [patent_app_number] => 8/454917 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 69 [patent_no_of_words] => 18496 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633392.pdf [firstpage_image] =>[orig_patent_app_number] => 454917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3827365 [patent_doc_number] => 05783594 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Cell differentiation induction with mevalonate and mevalonolactone derivatives' [patent_app_type] => 1 [patent_app_number] => 8/456116 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8909 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783594.pdf [firstpage_image] =>[orig_patent_app_number] => 456116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3716389 [patent_doc_number] => 05616612 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Urethanes and ureas that enhance the growth of bone marrow progenitor cells' [patent_app_type] => 1 [patent_app_number] => 8/451099 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19287 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 375 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616612.pdf [firstpage_image] =>[orig_patent_app_number] => 451099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805772 [patent_doc_number] => 05830874 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Compositions and methods for the treatment of arterial chlamydial granuloma' [patent_app_type] => 1 [patent_app_number] => 8/452652 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 28 [patent_no_of_words] => 15696 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830874.pdf [firstpage_image] =>[orig_patent_app_number] => 452652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695487 [patent_doc_number] => 05661125 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Stable and preserved erythropoietin compositions' [patent_app_type] => 1 [patent_app_number] => 8/448960 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5979 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661125.pdf [firstpage_image] =>[orig_patent_app_number] => 448960 [rel_patent_id] =>[rel_patent_doc_number] =>)